Buy Punjab National Bank, target of Rs 627: Karvy

Published on Fri, Aug 01, 2008 at 12:41 |  Source : Moneycontrol.com

Updated at Fri, Aug 29, 2008 at 12:42  

36480 Investors following PNB. Share this News with them.
0
0
Share on Tumblr

RELATED NEWS

ALSO READ

Karvy Stock Broking has rated Punjab National Bank as a buy with a target price of Rs 627 in its August 1, 2008 research report. "In 1QFY09, Punjab National Bank's reported net interest income of Rs 14.5 billion lower than our expectations mainly due to higher cost of funds; NIM also drifted down by 32 bps to 3.27%. The bank reported marginal growth of 5.6% (Y-o-Y) to Rs 4.6 billion. Contained operating expenses and lesser provisions led to 20.5% growth in bottomline."

"We are reducing our price target by 5.8% to Rs 627 per share to account for higher cost of funds; the bank may not be able to completely pass-on the higher cost of deposits going forward reflecting strain on margin. We reduce our earning estimates by 5.2% in FY2009 and 7.3% in FY2010. We rate the stock as a BUY with a target price of Rs 627 at 1.5x ABV FY2010," says Karvy's research report.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

For further details click on attachment......

Attachments : Daily 01-08-08.pdf

  

More on Moneycontrol

Trending News

Business News

Tech2's Nokia Lumia Contest is Live
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com